Inactive Instrument

Kaya Holdings, Inc. Share Price Other OTC

Equities

KAYS

US4865672095

Healthcare Facilities & Services

Sales 2022 685K 54.9M Sales 2023 196K 15.72M Capitalization 933K 74.77M
Net income 2022 -3M -240M Net income 2023 1M 80.1M EV / Sales 2022 13.5 x
Net Debt 2022 7.85M 629M Net Debt 2023 8.31M 666M EV / Sales 2023 47.1 x
P/E ratio 2022
-0.29 x
P/E ratio 2023
4.21 x
Employees -
Yield 2022 *
-
Yield 2023
-
Free-Float 80.35%
More Fundamentals * Assessed data
Dynamic Chart
Kaya Holdings, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Kaya Holdings, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
Kaya Holdings, Inc. Secures Site for the Sacred Mushroom(TM) Planned Psilocybin Treatment Center CI
Kaya Holdings, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
Kaya Holdings, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Kaya Holdings, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Kaya Holdings, Inc. Auditor Raises 'Going Concern' Doubt CI
Kaya Holdings, Inc. Launches Fifth Dimension Therapeutics to Seek to Provide Innovative Psychedelic-Based Treatments for Depression and Anxiety Related Conditions and Address the Growing Multi-Billion Dollar Global Psychedelics Market CI
Kaya Holdings, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022 CI
Kaya Holdings, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
Kaya Holdings, Inc. Reports Earnings Results for the Full Year Ended December 31, 2021 CI
Kaya Holdings, Inc. Auditor Raises 'Going Concern' Doubt CI
Kaya Holdings, Inc. Announces Management Changes CI
Kaya Holdings, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021 CI
Kaya Holdings, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2021 CI
More news
Managers TitleAgeSince
Chief Executive Officer 63 31/12/09
Compliance Officer - -
Members of the board TitleAgeSince
Chief Executive Officer 63 31/12/09
Director/Board Member 63 31/12/09
Director/Board Member 69 30/11/20
More insiders
Kaya Holdings, Inc is a holding company. The Company is focused on wellness and mental health through operations in psychedelic treatment clinics, medical and recreational cannabis, and cannabidiol (CBD) products. The Company produces, distributes, and/or sells a full range of cannabis products including flowers, oils, vape cartridges and cannabis infused confections, baked goods and beverages through a fully integrated group of subsidiaries and companies supporting highly distinctive brands. It operates through four subsidiaries, which include Marijuana Holdings Americas, Inc. (MJAI), Kaya Brand International, Inc. (KBI)., and Fifth Dimension Therapeutics, Inc. (FDT). MJAI maintains ownership of the Company’s Oregon-based cannabis operations. FDT provides psychedelic mind care treatments to veterans suffering from PTSD, addicts seeking to break addiction, individuals with eating disorders, and others with an array of treatment resistant mental health disorders.
More about the company